CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)
$4.5 0.01 (0.2227%)
Analysed CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) News Sources
CAMP4 Appoints Michael MacLean to its Board of Directors
24-03-2026
yahoo.com
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
18-03-2026
fool.com
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
18-03-2026
fool.com
Biotech Alert: Searches spiking for these stocks today
12-03-2026
yahoo.com
CAMP4 to Participate in Upcoming Investor Conferences
06-03-2026
yahoo.com
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
05-03-2026
yahoo.com
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20-02-2026
yahoo.com
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why
13-01-2026
yahoo.com
CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
06-01-2026
yahoo.com
Novo files for CagriSema approval; Merck and Pfizer’s trial win
19-12-2025
biopharmadive.com
What is the current price of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)?
The current price of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) is $4.5.
CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) absolute price change since previous trading day?
The absolute price change of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) since the previous trading day is $0.01.
CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) percentage price change since previous trading day?
The percentage price change of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) since the previous trading day is 0.2227%.
What is the most recent average sentiment score for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)?
The most recent average sentiment score for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)?
The most recent sentiment for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) is .
SEC-8K** Filing Available For CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.